Tag: US pharmaceutical market
GENERAL Glenmark Gets US FDA Approval For Fluticasone Propionate Nasal Spray

Glenmark Pharmaceuticals Ltd has received approval from the US Food and Drug Administration (US FDA) for Fluticasone Propionate Nasal Spray USP, 0.05 mg (50 mcg)/spray, strengthening its respiratory portfolio in the US market. The company said its Fluticasone Propionate Nasal Spray is bioequivalent and therapeutically equivalent to Flonase Nasal Spray, 0.05 mg/spray, the reference listed […]

CW Bureau · Aug 20, 2026
GENERAL Aurobindo Pharma Bets On Specialty Drugs, Biosimilars For Next Expansion

Aurobindo Pharma Ltd is doubling down on high-value specialty medicines, biosimilars and complex formulations while strengthening its manufacturing footprint and supply chain resilience as it charts its next phase of global growth. In his message to shareholders in the company’s Annual Report 2026, Vice Chairman & Managing Director K. Nithyananda Reddy said the company will […]

CW Bureau · Aug 4, 2026